Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules

Molecular and Cellular Proteomics

Volumn 9, Issue 9, 2010, Pages 2034-2047

  De Verteuil, Danielle ^a,b   Muratore Schroeder, Tara L ^a,b   Granados, Diana P ^a,b   Fortier, Marie Hélène ^a,b   Hardy, Marie Pierre ^a,b   Bramoullé, Alexandre ^a,b   Caron, Étienne ^a,b   Vincent, Krystel ^a,b   Mader, Sylvie ^a   Lemieux, Sébastien ^a   Thibault, Pierre ^a,b   Perreault, Claude ^a,b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CALNEXIN; IMMUNOPROTEASOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PEPTIDE DERIVATIVE; PROTEASOME; PROTEIN LMP7; PROTEIN MECL1; PROTEIN SUBUNIT; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CELL FUNCTION; CELL SPECIFICITY; CELL TYPE; CHROMOSOME 4; CHROMOSOME 8; CONTROLLED STUDY; DENDRITIC CELL; ELUTION; EUKARYOTE; GENE CLUSTER; GENE EXPRESSION; GENE SEGREGATION; GENETIC TRANSCRIPTION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; THYMOCYTE; VERTEBRATE;

ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; TANDEM MASS SPECTROMETRY;

EUKARYOTA; GNATHOSTOMATA (VERTEBRATE); IPS;

EID: 77956533051     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M900566-MCP200     Document Type: Article

References (60)

1. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771
2. Wherry, E. J., Golovina, T. N., Morrison, S. E., Sinnathamby, G., McElhaugh, M. J., Shockey, D. C., and Eisenlohr, L. C. (2006) Re-evaluating the generation of a "proteasome-independent" MHC class I-restricted CD8 T cell epitope. J. Immunol. 176, 2249-2261
3. Loureiro, J., and Ploegh, H. L. (2006) Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv. Immunol. 92, 225-305
4. Shastri, N., Cardinaud, S., Schwab, S. R., Serwold, T., and Kunisawa, J. (2005) All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol. Rev. 207, 31-41 (Pubitemid 41415006)
5. Glickman, M. H., and Ciechanover, A. (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373-428
6. Deshaies, R. J., and Joazeiro, C. A. (2009) RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434
7. Kloetzel, P. M. (2001) Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2, 179-187
8. Heink, S., Ludwig, D., Kloetzel, P. M., and Kruger, E. (2005) IFN-γ-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc. Natl. Acad. Sci. U.S.A. 102, 9241-9246 (Pubitemid 40923548)
9. Macagno, A., Kuehn, L., de Giuli, R., and Groettrup, M. (2001) Pronounced up-regulation of the PA28α/β proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation. Eur. J. Immunol. 31, 3271-3280 (Pubitemid 33100519)
10. Hughes, A. L. (1997) Evolution of the proteasome components. Immunogenetics 46, 82-92
11. Kesmir, C., van Noort, V., de Boer, R. J., and Hogeweg, P. (2003) Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome. Immunogenetics 55, 437-449 (Pubitemid 37378484)
12. Zaiss, D. M., de Graaf, N., and Sijts, A. J. (2007) The proteasome immunosubunit MECL-1 is a T cell intrinsic factor influencing homeostatic expansion. Infect. Immun. 76, 1207-1213
13. Sewell, A. K., Price, D. A., Teisserenc, H., Booth, B. L. J., Gileadi, U., Flavin, F. M., Trowsdale, J., Phillips, R. E., and Cerundolo, V. (1999) IFN-γ exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. J. Immunol. 162, 7075-7079
14. Morel, S., Lévy, F., Burlet-Schiltz, O., Brasseur, F., Probst-Kepper, M., Peitrequin, A. L., Monsarrat, B., Van Velthoven, R., Cerottini, J. C., Boon, T., Gairin, J. E., and Van den Eynde, B. J. (2000) Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12, 107-117
15. + T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193, 1319-1326
16. Chapiro, J., Claverol, S., Piette, F., Ma, W., Stroobant, V., Guillaume, B., Gairin, J. E., Morel, S., Burlet-Schiltz, O., Monsarrat, B., Boon, T., and Van den Eynde, B. J. (2006) Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation. J. Immunol. 176, 1053-1061 (Pubitemid 43099706)
17. Deol, P., Zaiss, D. M. W., Monaco, J. J., and Sijts, A. J. A. M. (2007) Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes. J. Immunol. 178, 7557-7562
18. Dannull, J., Lesher, D. T., Holzknecht, R., Qi, W., Hanna, G., Seigler, H., Tyler, D. S., and Pruitt, S. K. (2007) Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate anti-tumor immunity. Blood 110, 4341-4350
19. Cascio, P., Hilton, C., Kisselev, A. F., Rock, K. L., and Goldberg, A. L. (2001) 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 20, 2357-2366
20. Mishto, M., Luciani, F., Holzhutter, H. G., Bellavista, E., Santoro, A., Textoris-Taube, K., Franceschi, C., Kloetzel, P. M., and Zaikin, A. (2008) Modeling the in vitro 20S proteasome activity: the effect of PA28-αβ and of the sequence and length of polypeptides on the degradation kinetics. J. Mol. Biol. 377, 1607-1617
21. Kloetzel, P.-M., and Ossendorp, F. (2004) Proteasome and peptidase function in MHC-class-I mediated antigen presentation. Curr. Opin. Immunol. 16, 76-81
22. Yewdell, J. W., Reits, E., and Neefjes, J. (2003) Making sense of mass destruction: quantitating MHC class I antigen presentation. Nature Rev. Immunol. 3, 952-961 (Pubitemid 37521537)
23. Eisenlohr, L. C., Huang, L., and Golovina, T. N. (2007) Rethinking peptide supply to MHC class I molecules. Nat. Rev. Immunol. 7, 403-410
24. York, I. A., Mo, A. X. Y., Lemerise, K., Zeng, W., Shen, Y., Abraham, C. R., Saric, T., Goldberg, A. L., and Rock, K. L. (2003) The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 18, 429-440
25. Hammer, G. E., Kanaseki, T., and Shastri, N. (2007) The final touches make perfect the peptide-MHC class I repertoire. Immunity 26, 397-406 (Pubitemid 46603005)
26. Wearsch, P. A., and Cresswell, P. (2007) Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat. Immunol. 8, 873-881
27. Lipford, J. R., and Deshaies, R. J. (2003) Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nat. Cell Biol. 5, 845-850
28. Lipford, J. R., Smith, G. T., Chi, Y., and Deshaies, R. J. (2005) A putative stimulatory role for activator turnover in gene expression. Nature 438, 113-116 (Pubitemid 41599830)
29. Collins, G. A., and Tansey, W. P. (2006) The proteasome: a utility tool for transcription? Curr. Opin. Genet. Dev. 16, 197-202
30. Bhaumik, S. R., and Malik, S. (2008) Diverse regulatory mechanisms of eukaryotic transcriptional activation by the proteasome complex. Crit Rev. Biochem. Mol. Biol. 43, 419-433
31. Fortier, M. H., Caron, E., Hardy, M. P., Voisin, G., Lemieux, S., Perreault, C., and Thibault, P. (2008) The MHC class I peptide repertoire is molded by the transcriptome. J. Exp. Med. 205, 595-610 (Pubitemid 351439307)
32. Wells, J. W., Darling, D., Farzaneh, F., and Galea-Lauri, J. (2005) Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions. Scand. J. Immunol. 61, 251-259 (Pubitemid 40462775)
33. Son, Y. I., Egawa, S., Tatsumi, T., Redlinger, R. E., Jr., Kalinski, P., and Kanto, T. (2002) A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J. Immunol. Methods 262, 145-157
34. Brochu, S., Baron, C., Hetu, F., Roy, D. C., and Perreault, C. (1995) Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras. J. Immunol. 155, 5104-5114
35. Lynn, D. J., Winsor, G. L., Chan, C., Richard, N., Laird, M. R., Barsky, A., Gardy, J. L., Roche, F. M., Chan, T. H., Shah, N., Lo, R., Naseer, M., Que, J., Yau, M., Acab, M., Tulpan, D., Whiteside, M. D., Chikatamarla, A., Mah, B., Munzner, T., Hokamp, K., Hancock, R. E., and Brinkman, F. S. (2008) InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol. Syst. Biol. 4, 218
36. Peters, B., and Sette, A. (2007) Integrating epitope data into the emerging web of biomedical knowledge resources. Nat. Rev. Immunol. 7, 485-490
37. + T cells in vivo. Eur. J. Immunol. 30, 1356-1363
38. Lecoeur, H., Fevrier, M., Garcia, S., Riviere, Y., and Gougeon, M. L. (2001) A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods 253, 177-187
39. Jedema, I., van der Werff, N. M., Barge, R. M., Willemze, R., and Falkenburg, J. H. (2004) New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 103, 2677-2682
40. Ferron, F., Longhi, S., Canard, B., and Karlin, D. (2006) A practical overview of protein disorder prediction methods. Proteins 65, 1-14
41. Zhang, B., Kirov, S., and Snoddy, J. (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33(Web Server Issue), W741-W748
42. Huang, D. W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
43. Groettrup, M., Standera, S., Stohwasser, R., and Kloetzel, P. M. (1997) The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc. Natl. Acad. Sci. U.S.A. 94, 8970-8975
44. Toes, R. E., Nussbaum, A. K., Degermann, S., Schirle, M., Emmerich, N. P., Kraft, M., Laplace, C., Zwinderman, A., Dick, T. P., Muller, J., Schonfisch, B., Schmid, C., Fehling, H. J., Stevanovic, S., Rammensee, H. G., and Schild, H. (2001) Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194, 1-12
45. Schatz, M. M., Peters, B., Akkad, N., Ullrich, N., Martinez, A. N., Carroll, O., Bulik, S., Rammensee, H. G., van, E. P., Holzhutter, H. G., Tenzer, S., and Schild, H. (2008) Characterizing the N-terminal processing motif of MHC class I ligands. J. Immunol. 180, 3210-3217
46. Reits, E., Neijssen, J., Herberts, C., Benckhuijsen, W., Janssen, L., Drijfhout, J. W., and Neefjes, J. (2004) A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20, 495-506
47. Hammer, G. E., Gonzalez, F., Champsaur, M., Cado, D., and Shastri, N. (2006) The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat. Immunol. 7, 103-112
48. Gsponer, J., Futschik, M. E., Teichmann, S. A., and Babu, M. M. (2008) Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science 322, 1365-1368
49. Gsponer, J., and Madan, B. M. (2009) The rules of disorder or why disorder rules. Prog. Biophys. Mol. Biol. 99, 94-103
50. Hughes, A. L., and Hughes, M. K. (1995) Self peptides bound by HLA class I molecules are derived from highly conserved regions of a set of evolutionarily conserved proteins. Immunogenetics 41, 257-262
51. Engelhard, V., Brickner, A., and Zarling, A. (2002) Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire. Mol. Immunol. 39, 127-137
52. Ho, Y. K., Bargagna-Mohan, P., Wehenkel, M., Mohan, R., and Kim, K. B. (2007) LMP2-specific inhibitors: chemical genetic tools for proteasome biology. Chem. Biol. 14, 419-430
53. Gileadi, U., Moins-Teisserenc, H. T., Correa, I., Booth, B. L., Jr., Dunbar, P. R., Sewell, A. K., Trowsdale, J., Phillips, R. E., and Cerundolo, V. (1999) Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J. Immunol. 163, 6045-6052
54. Vavouri, T., Semple, J. I., Garcia-Verdugo, R., and Lehner, B. (2009) Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell 138, 198-208
55. Caron, É., Charbonneau, R., Huppé, G., Brochu, S., and Perreault, C. (2005) The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome. Int. Immunol. 17, 1583-1596
56. Groettrup, M., Kirk, C. J., and Basler, M. (2010) Proteasomes in immune cells: more than peptide producers? Nat. Rev. Immunol. 10, 73-78
57. Caudill, C. M., Jayarapu, K., Elenich, L., Monaco, J. J., Colbert, R. A., and Griffin, T. A. (2006) T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J. Immunol. 176, 4075-4082
58. Muchamuel, T., Basler, M., Aujay, M. A., Suzuki, E., Kalim, K. W., Lauer, C., Sylvain, C., Ring, E. R., Shields, J., Jiang, J., Shwonek, P., Parlati, F., Demo, S. D., Bennett, M. K., Kirk, C. J., and Groettrup, M. (2009) A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat. Med. 15, 781-787
59. Hurst, L. D., Pal, C., and Lercher, M. J. (2004) The evolutionary dynamics of eukaryotic gene order. Nat. Rev. Genet. 5, 299-310
60. Sproul, D., Gilbert, N., and Bickmore, W. A. (2005) The role of chromatin structure in regulating the expression of clustered genes. Nat. Rev. Genet. 6, 775-781